Risperidone in acute and continuation treatment of mania

International Clinical Psychopharmacology

Volumn 18, Issue 4, 2003, Pages 227-235

  Yatham, Lakshmi N ^a   Binder, Carin ^d   Riccardelli, Rosanna ^d   Leblanc, Jean ^b   Connolly, Mary ^a   Kusumakar, Vivek ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d Wesbrook Mall ^*

Author keywords

Acute treatment; Continuation treatment; Depression; Mania; Risperidone

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; PLACEBO; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERKINESIA; MAJOR CLINICAL STUDY; MALE; MANIA; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE; TREMOR;

EID: 0038102784     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200307000-00005     Document Type: Article

References (33)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association.
2. Borison RL, Pathiraja AP, Diamond BI, Melbach RC (1992). Risperidone: clinical safety and efficacy in schizophrenia. Paychopharmacol Bull 28:213-218.
3. Bowden CL, Brugger AM, Swarm AC, Calabrese JR, Janicak PG, Petty F, et al. (1994). Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271:918-924.
4. Calabrese JR, Bowden CL, Sachs GS, Aacher JA, Monaghan E, Rudd GD (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60:79-88.
5. Casey DE (1999). Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res 35(suppl):S61-S66.
6. Chou JC (1991). Recent advances in treatment of acute mania. J Clin Psychopharmacol 11:3-21.
7. Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980). Extrapyramidal Symptom Rating Scale (abstract). Can J Neurol Sci 7:233.
8. Conley RR, Mahmoud R (2001). A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry 158:765-774.
9. Dilsaver SC, Swann AC, Shoaib AM, Bowers TC, Halle MT (1993). Depressive mania associated with nonresponse to antimanic agents. Am J Psychiatry 150:1548-1551.
10. Esparon J, Kolloori J, Naylor GJ, McHarg AM, Smith AH, Hopwood SE (1986). Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry 148:723-725.
11. Ghadirian AM, Annable L, Belanger MC, Chouinard G (1996). A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. J Clin Psychiatry 57:22-28.
12. Goodwin FK, Jamison KR (1990). Manic depressive illness. Oxford: Oxford University Press.
13. Guy W (1976.) ECDEU assessment manual for psychopharmacology, US Dept Health, Education, and Welfare Publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health.
14. Hamilton M (1967). Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
15. Johnstone EC, Frith CD, Crow TJ, Owens DG, Done DJ, Baldwin EJ, Charlette A (1988). The Northwick Park 'functional' psychosis study: diagnosis and treatment response. Lancet 2:119-125.
16. Kane JM (1988). The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 49(suppl):12-14.
17. Keck PE, McElroy SL, Strakowski SM, Balistreri TM, Kizer DI, West SA (1996). Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 57:147-151.
18. Marder SR, Davis JM, Chouinard G (1997). The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 58:538-546.
19. Nasrallah HA, Churchill CM, Hamdan-Allan GA (1988). Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 145:1455-1456.
20. Overall JE, Gorham DR (1962). The Brief Psychiatric Rating Scale. Psychol Reports 10:799-812.
21. Peuskens J (1995). Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry 166:712-726.
22. Sachs GS (2000). Safety and efficacy of risperidone versus placebo in combination with lithium or valproate in the treatment of the manic phase of the Bipolar Disorder. Int J Neuropsychopharmacol 3(suppl 1):S143.
23. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL (2002). Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 159:1146-1154.
24. Segal J, Berk M, Brook S (1998). Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21:176-180.
25. Sernyak MJ, Griffin RA, Johnson RM, Pearsall HR, Wexler BE, Woods SW (1994). Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J.Psychiatry 151:133-135.
26. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, et al. (1997). Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54:37-42.
27. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG et al. (1999). Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 156:702-709.
28. Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, et al. (2000). Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 57:841-849.
29. Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martinez G, et al. (2001). Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: Results from a 6-month multicenter open study. J Clin Psychiatry 62:818-825.
30. White E, Cheung P, Silverstone T (1993). Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 8:119-122.
31. Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A (2003). Mood stabilizer plus risperidone or placebo in the treatment of acute mania: International, double blind, randomized, controlled trial. Br J Psychiatry 182:141-147.
32. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435.
33. Zarate CA, Jr, Tohen M (2000). Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry 61:33-38.